Piper Sandler News Releases


News Releases  |  In the News
NEW YORK, Feb 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- In an effort to provide clients the best proprietary and in-depth research analysis in the medical technology sector, Piper Jaffray announces it has hired Suraj Kalia to join the Piper Jaffray Investment Research team. Kalia will broaden the firm's coverage of the medical technology sector. He will be based in the firm's New York office.

Kalia has more than 15 years of experience working in the financial and health care industries. Most recently, he was a senior medical device analyst at Rodman & Renshaw, LLC in New York. He was ranked No. 1 by and No. 5 in the 2005 Wall Street Journal's "Best on the Street" survey in the medical devices sector. In his career, he also spent seven years as project and team manager of the mergers and acquisitions practice at Entegris Inc., a semiconductor company. Additionally, he worked in investment banking for Tata Capital in Bombay, India, for four years.

"Extending our research product offering in the medical technology sector will offer our clients additional proprietary and in-depth analysis," said Joel Denney, head of Investment Research. "Suraj's deep health care, engineering and financial knowledge has brought him to the top research rankings in the medical technology sector. We look forward to having his capabilities included on our health care team."

Kalia has a bachelor's degree in chemical engineering from the Indian Institute of Technology in Bombay, India, a master's degree in chemical engineering at Stevens Institute of Technology in Hoboken, N.J. and a master's of business administration degree at the University of St. Thomas in Minneapolis. He also holds the Chartered Financial Analyst (CFA) designation.

About Piper Jaffray

Piper Jaffray Companies is a leading, international middle market investment bank and institutional securities firm, serving the needs of middle market corporations, private equity groups, public entities, nonprofit clients and institutional investors. Founded in 1895, Piper Jaffray provides a comprehensive set of products and services, including equity and debt capital markets products; public finance services; mergers and acquisitions advisory services; high-yield and structured products; institutional equity and fixed- income sales and trading; and equity and high-yield research. With headquarters in Minneapolis, Piper Jaffray has 25 offices across the United States and international locations in London, and Shanghai. The firm's UK operating subsidiary, Piper Jaffray Ltd., is authorized and regulated by the Financial Services Authority and is a member of the London Stock Exchange. Piper Jaffray & Co. is the firm's principal operating subsidiary. (NYSE: PJC) ( )

Since 1895. Member SIPC and NYSE.

SOURCE Piper Jaffray

Susan Beatty, Media Relations, of Piper Jaffray & Co., +1-612-303-5680